Lost life years attributable to stroke among patients with nonvalvular atrial fibrillation: A nationwide population-based follow-up study

Neuroepidemiology

Volumn 29, Issue 1-2, 2007, Pages 59-65

  Frost, Lars ^a   Vukelic Andersen, Ljubica ^a   Johnsen, Søren Paaske ^a   Mortensen, Leif Spange ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNI C   (Denmark)

Author keywords

Arrhythmia; Epidemiology; Mortality; Stroke

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTRIBUTABLE RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; MIGRATION; POPULATION; PROPORTIONAL HAZARDS MODEL; SEX RATIO; STROKE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; DENMARK; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; SEX DISTRIBUTION; STROKE; SURVIVAL RATE;

EID: 36549070130     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109497     Document Type: Article

References (22)

1. Feigin VL, Lawes CM, Bennett DA, Anderson CS: Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
2. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al: Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-1933.
3. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-1564.
4. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al: Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760-1764.
5. Dulli DA, Stanko H, Levine RL: Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 2003;22:118-123.
6. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al: Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005;36:1115-1119.
7. Frost L, Vestergaard P, Mosekilde L, Mortensen LS: Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol 2005;103:78-84.
8. Frost L, Vukelic Andersen L, Godtfredsen J, Mortensen LS: Age and risk of stroke in atrial fibrillation: evidence for guidelines? Neuroepidemiology 2007;28:109-115.
9. Frost L, Vukelic Andersen L, Vestergaard P, Husted S, Mortensen LS: Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002. Neuroepidemiology 2006;26:212-219.
10. Frost L, Vukelic Andersen L, Mortensen LS, Dethlefsen C: Seasonal variation in stroke and stroke-associated mortality in patients with a hospital diagnosis of nonvalvular atrial fibrillation or flutter. A population-based study in Denmark. Neuroepidemiology 2006;26:220-225.
11. Frost L, Andersen LV, Vestergaard P, Husted S, Mortensen LS: Trend in mortality after stroke with atrial fibrillation. Am J Med 2007;120:47-53.
12. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH: The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-268.
13. National Institute of Neurological Disorders and Stroke Ad Hoc Committee: Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases: III. Stroke 1990;21:637-676.
14. Aguilar MI, Hart R: Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2005;3:CD001927.
15. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, et al: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-1026.
16. Torp-Pedersen C, Kober L: Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Lancet 1999;354:9-12.
17. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, et al: Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-2477.
18. Korantzopoulos P, Kolettis TM: Obesity and the risk of new-onset atrial fibrillation. JAMA 2005;293:1974.
19. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al: Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-3010.
20. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Gronbaek M: Alcohol consumption and risk of atrial fibrillation in men and women: The Copenhagen City Heart Study. Circulation 2005;112:1736-1742.
21. Frost L, Johnsen SP, Pedersen L, Toft E, Husted S, Sorensen HT: Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice. J Intern Med 2002;252:64-69.
22. Friberg J, Gislason GH, Gadsboll N, Rasmussen JN, Rasmussen S, Abildstrom SZ, et al: Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation. J Intern Med 2006;259:173-178.